Results 351 to 360 of about 2,266,569 (385)
Some of the next articles are maybe not open access.
Immune checkpoint therapy—current perspectives and future directions
Cell, 2023Padmanee Sharma +15 more
semanticscholar +1 more source
Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade
New England Journal of Medicine, 2018M. Postow, R. Sidlow, M. Hellmann
semanticscholar +1 more source
The future of immune checkpoint therapy
Science, 2015Padmanee Sharma, J. Allison
semanticscholar +1 more source
2018
Immune checkpoint inhibitors (ICI) represent a class of immuno-oncology drugs consisting of monoclonal antibodies occurring against inhibitory receptors or ligands within the immune system including CTLA-4, PD-1, and PD-L1. ICI has transformed oncology in the last decade leading to increased response rates and improved overall survival across several ...
Sarah Sammons +3 more
openaire +1 more source
Immune checkpoint inhibitors (ICI) represent a class of immuno-oncology drugs consisting of monoclonal antibodies occurring against inhibitory receptors or ligands within the immune system including CTLA-4, PD-1, and PD-L1. ICI has transformed oncology in the last decade leading to increased response rates and improved overall survival across several ...
Sarah Sammons +3 more
openaire +1 more source
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Nature reviews. Drug discovery, 2021A. Korman +2 more
semanticscholar +1 more source
Checkpoints in antibacterial immunity
Research in Immunology, 1998Flesch, I. +3 more
openaire +3 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly